Evidence map›Paper›PMID 41247063›Full record

SynthesisHuman vaccines & immunotherapeutics2025

A systematic review of demographic and socioeconomic characteristics associated with inequalities in invasive meningococcal disease prevention in high-income countries and Latin America.

Zeki Kocaata, Shahina Begum, Anar Andani, Ifeanyi Michael Ubamadu, Catherine Rolland

Abstract readSystematic Review
In one paragraph

Synthesis in Human vaccines & immunotherapeutics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Zeki KocaataGSK, Munich, Germany.ORCID 0000-0002-5231-3389
Shahina BegumGSK, London, UK.ORCID 0000-0002-3521-8865
Anar AndaniGSK, London, UK.ORCID 0000-0003-0530-5340
Ifeanyi Michael UbamaduGSK, London, UK.ORCID 0000-0002-8081-982X
Catherine RollandDepartment of Evidence Synthesis, Evidera, The Ark, London, UK.ORCID 0009-0004-6962-2008

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Invasive meningococcal disease (IMD) is an uncommon and often fatal disease. Although IMD vaccines are widely available in high-income countries, vaccination access and receipt vary. To identify factors associated with IMD prevention inequalities across high-income countries and Latin America, a systematic literature review (SLR) of four databases (Embase, MEDLINE/MEDLINE In-Process, The Cochrane Library, EconLit; 2012-2023), and recent congress proceedings was conducted. In total, 68 studies reported inequalities in IMD prevention and were included in the analysis, across North America, Latin America, Europe, and the Western Pacific. Despite increased vaccination opportunities, inequalities in IMD prevention remain, associated with demographic and socioeconomic characteristics such as age, sex, income, and quality healthcare access. Poor IMD vaccination rates were associated with low IMD knowledge/awareness, negative attitudes toward vaccination, and low educational attainment. This SLR identified knowledge gaps regarding IMD prevention, highlighted underserved populations, and may inform policy changes to improve IMD-related health equity.

Indexed as

Healthcare DisparitiesMeningococcal InfectionsMeningococcal VaccinesDeveloped CountriesHealth Knowledge, Attitudes, PracticeHumansLatin AmericaSocioeconomic FactorsVaccinationMeningococcal Vaccinesbacterial meningitishealth equityinequalityinequityInvasive meningococcal diseaseprevention

Identifiers

PMID41247063
PMCPMC12629335

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.